Search Within

David Hyman

  1. "Diana Mandelker"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (10)
  3. Research Letter (1)
Groups
  1. Department of Medicine (22)
  2. Department of Pathology and Laboratory Medicine (22)
  3. Early Drug Development Service (22)
  4. GSK Faculty (22)
  5. Human Oncology and Pathogenesis Program (22)
  6. Solid Tumor Oncology Division (22)

More Groups

People
  1. Diana Mandelker (22)
  2. Michael Berger (20)
  3. David Solit (17)
  4. Marc Ladanyi (17)
  5. Mark Robson (16)
  6. Kenneth Offit (15)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (9)
  4. 2018 (5)
  5. 2017 (5)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Research (3)
  3. Blood (2)
  4. JAMA Oncology (2)
  5. JCO Precision Oncology (2)
  6. Nature Genetics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Nature Publishing Group (5)
  3. American Association for Cancer Research (4)
  4. American Medical Association (3)
  5. American Society of Hematology (2)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumour lineage shapes BRCA-mediated phenotypes
    Research Letter

    Jonsson, P.; Bandlamudi, C.; Cheng, M. L.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors
    Journal Article

    Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; Bolton, K.; Yelskaya, Z.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Carlo, M. I.; Mukherjee, S.; Kemel, Y.; Zhang, L.; Mandelker, D.; Vijai, J.; Coskey, D. T.; Pradhan, N.; Hyman, D. M.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save